Investment Summary

Becton Dickinson Invests In Babson Diagnostics

On October 8, 2024, Becton Dickinson invested in healthcare services company Babson Diagnostics

Investment Highlights
  • This is Becton Dickinson’s 7th transaction in the Healthcare Services sector.
  • This is Becton Dickinson’s 23rd transaction in the United States.
  • This is Becton Dickinson’s 2nd transaction in Texas.

Investment Summary
Date 2024-10-08
Target Babson Diagnostics
Sector Healthcare Services
Investor(s) Becton Dickinson
Deal Type Growth Capital

Target

Babson Diagnostics

Austin, Texas, United States
Babson Diagnostics is a science-first healthcare technology company reimagining the diagnostic blood testing experience. The company uses capillary blood for routine testing and developed technologies representing a new standard in diagnostics. Babson Diagnostics is based in Austin, Texas.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Becton Dickinson

Franklin Lake, New Jersey, United States
Category Company
Founded 1897
Sector Medical Products
Employees75,000
Revenue 19.4B USD (2023)
DESCRIPTION

Becton Dickinson is a global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. Becton Dickinson was incorporated in 1897 and is headquartered in Franklin Lake, New Jersey.

DEAL STATS #
Overall 30 of 30
Sector (Healthcare Services) 7 of 7
Type (Growth Capital) 1 of 1
State (Texas) 2 of 2
Country (United States) 23 of 23
Year (2024) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-10 Vyaire Medical

Mettawa, Illinois, United States

Vyaire Medical supports and improves the lives of patients with a laser focus on improving patient outcomes and increasing value for customers. The company was to serve healthcare customers with innovative device and service solutions across the respiratory and anesthesia continua of care. Vyaire's legacy brands have a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, ventilation, and anesthesia delivery & patient monitoring. From industry-pioneering brands that include Bird, Bear, and Jaeger to respected industry leaders AirLife, Vital Signs, Viasys, and many others - Vyaire Medical has nearly 27,000 distinct part numbers recognized, trusted, and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide. Vyaire Medical was formed in 2016 and is based in Mettawa, Illinois.

Sell -
Mergr

Product

Company

Legal